PekingUTH
Beijing, Beijing Municipality, China
NCT Number: NCT04977505
This study aims to analyze the absorption rate of Pushlock anchors and Gryphon anchors and the bone ingrowth of the anchor channel by consulting the postoperative CT images of patients with recurrent shoulder dislocation completed by myself. The investigators will analyze the influence factors of anchor absorption and bone ingrowth, which will provide a reference for improving anchor design and the improvement of surgical techniques.
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, Beijing Municipality, China
"Recurrent anterior dislocation of the shoulder joint is a common disease of the shoulder joint. The standard treatment methods include soft tissue repair surgery and bone tissue repair surgery. The former refers to arthroscopic labral suture (Bankart repair surgery), and the latter includes Latarjet surgery, Bristow surgery and Cuistow surgery pioneered by our team. Whether it is soft tissue repair surgery or bone tissue repair surgery, anchors are required for suture fixation during the operation.
The anchors currently in use include non-absorbable anchors and absorbable anchors. Non-absorbable anchors include metal anchors and peek material anchors, which remain in the body forever after the operation and cannot be absorbed. The absorbable anchors, in theory, will be absorbed 2 years after surgery.
Non-absorbable anchors have inherent limitations that limit their use. If the non-absorbable anchor loosens and shifts, it can cause severe cartilage damage. If complications such as re-dislocation occurred, revision surgery is required. Revision surgery is complicated because the non-absorbable anchor inserted in the initial surgery occupies the best anchor position. Metal anchors can cause artifacts and affect postoperative MRI imaging.
Therefore, absorbable anchors have gradually become routinely used in shoulder joint dislocation surgery.
The anchors currently used in our hospital for shoulder joint instability include Pushlock anchors from Arthrex and Gryphon anchors from Depuy Mitek. The materials are PLLA/β-TCP and PLGA/β-TCP. The absorption anchor starts to absorb in 1 year and completes absorption in about two years. The anchor tunnel will be filled with bone tissue. However, the investigators have found that the anchor cannot be wholly absorbed as scheduled. During the revision surgery, the original absorbable anchor can still be seen. Clear anchor tunnels can also be seen in CT films after 2 years postoperatively.
Published literature also show that the degradation rate of absorbable anchors is not the same. The literature report that anchors have not completed degradation and bone ingrowth within the time advertised by the manufacturers.
In summary, this study aims to analyze the absorption rate of Pushlock anchors and Gryphon anchors and the bone ingrowth of the anchor tunnel by consulting the postoperative CT films of subjects with recurrent shoulder dislocation completed by myself. The factors that affect anchor absorption and bone ingrowth provide a reference for improving anchor design and the improvement of surgical techniques.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The surgery procedure was performed with pushlock for fixation
The surgery procedure was performed with Gryphon for fixation
Time frame: 2 years after surgery
It is an index used to evaluate the status of bone resorption. It was recorded of last CT films.
Time frame: 2 years after surgery
It is an index used to evaluate the status of bone resorption. It can be measured in the last CT films.
Time frame: 2 years after surgery
It is an index used to evaluate the status of bone resorption. It was recorded of last CT films.
Time frame: 2 years after surgery
It is an index used to evaluate the status of bone resorption. It can be measured in the last CT films.
Time frame: 2 years after surgery
It is a standard score used to qualify the status of ossification.
Peking University Third Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07544485
Disease Attributes, Emergencies
Basel, Switzerland
View Trial DetailsNCT06470789
Blood Flow Restriction Training, Joint Diseases
Wuhan, Hubei, China
View Trial DetailsNCT05443295
Behavior, Fatigue
Málaga, Spain
View Trial DetailsNCT03154957
Joint Diseases, Joint Dislocations
Strasbourg, France
View Trial Details